Amy Hunckler, Senior Consultant, Oliver Wyman

Amy Hunckler is a Senior Consultant with Oliver Wyman in the Health & Life Sciences practice specializing in drug R&D and commercial strategies for clients in the pharmaceutical and biotechnology sectors.  She has particular expertise in new product market access, indication and M&A target prioritization, and qualitative and quantitative market research. Amy has worked in a number of therapeutic areas, including Oncology, Immunology, Gastroenterology, and Rare Diseases. Prior to joining Oliver Wyman, Amy was a consultant at a boutique life sciences strategy firm and worked on engagements across the pharmaceutical, biotechnology, medical device, and diagnostics industries. Amy received Bachelors degrees in Biology and Economics from Brown University.